Bosentan (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bosentan" in French language version.

refsWebsite

Global rank French rank

4^th place

12^th place

2^nd place

3^rd place

2,374^th place

298^th place

149^th place

80^th place

3,608^th place

659^th place

low place

4,703^rd place

low place

7,855^th place

ahajournals.org

(en) Galiè N, Beghetti M, Gatzoulis MA, Granton J, Breathe-5 investigators et al., « Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study », Circulation, vol. 114, n^o 1,‎ 2006, p. 48–54. (PMID 16801459, DOI 10.1161/CIRCULATIONAHA.106.630715, résumé)

(en) Sitbon O, Gressin V, Speich R, Macdonald PS, Simonneau G et al., « Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension », Am J Respir Crit Care Med, vol. 170, n^o 11,‎ 2004, p. 1212–7. (PMID 15317666, DOI 10.1164/rccm.200404-445OC, résumé)

(en) Rubin LJ, Badesch DB, Barst RJ, Galie N, Simonneau G et al., « Bosentan therapy for pulmonary arterial hypertension », N Engl J Med, vol. 346, n^o 12,‎ 2002, p. 896–903. (PMID 11907289, DOI 10.1056/NEJMoa012212, lire en ligne)
(en) Galiè N, Rubin L, Hoeper M et al., « Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial », Lancet, vol. 371, n^o 9630,‎ 2008, p. 2093–2100 (PMID 18572079, DOI 10.1016/S0140-6736(08)60919-8, lire en ligne)
(en) Galiè N, Beghetti M, Gatzoulis MA, Granton J, Breathe-5 investigators et al., « Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study », Circulation, vol. 114, n^o 1,‎ 2006, p. 48–54. (PMID 16801459, DOI 10.1161/CIRCULATIONAHA.106.630715, résumé)
(en) Sitbon O, Gressin V, Speich R, Macdonald PS, Simonneau G et al., « Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension », Am J Respir Crit Care Med, vol. 170, n^o 11,‎ 2004, p. 1212–7. (PMID 15317666, DOI 10.1164/rccm.200404-445OC, résumé)
(en) Hoeper MM, Halank M, Marx C, Hoeffken G, Winkler J et al., « Bosentan therapy for portopulmonary hypertension », Eur Respir J, vol. 25, n^o 3,‎ 2005, p. 502–8. (PMID 15738295, DOI 10.1183/09031936.05.00080804, résumé)

(en) Hoeper MM, Halank M, Marx C, Hoeffken G, Winkler J et al., « Bosentan therapy for portopulmonary hypertension », Eur Respir J, vol. 25, n^o 3,‎ 2005, p. 502–8. (PMID 15738295, DOI 10.1183/09031936.05.00080804, résumé)

(en) Rubin LJ, Badesch DB, Barst RJ, Galie N, Simonneau G et al., « Bosentan therapy for pulmonary arterial hypertension », N Engl J Med, vol. 346, n^o 12,‎ 2002, p. 896–903. (PMID 11907289, DOI 10.1056/NEJMoa012212, lire en ligne)

(en) Rubin LJ, Badesch DB, Barst RJ, Galie N, Simonneau G et al., « Bosentan therapy for pulmonary arterial hypertension », N Engl J Med, vol. 346, n^o 12,‎ 2002, p. 896–903. (PMID 11907289, DOI 10.1056/NEJMoa012212, lire en ligne)
(en) Galiè N, Rubin L, Hoeper M et al., « Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial », Lancet, vol. 371, n^o 9630,‎ 2008, p. 2093–2100 (PMID 18572079, DOI 10.1016/S0140-6736(08)60919-8, lire en ligne)
(en) Galiè N, Beghetti M, Gatzoulis MA, Granton J, Breathe-5 investigators et al., « Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study », Circulation, vol. 114, n^o 1,‎ 2006, p. 48–54. (PMID 16801459, DOI 10.1161/CIRCULATIONAHA.106.630715, résumé)
(en) Sitbon O, Gressin V, Speich R, Macdonald PS, Simonneau G et al., « Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension », Am J Respir Crit Care Med, vol. 170, n^o 11,‎ 2004, p. 1212–7. (PMID 15317666, DOI 10.1164/rccm.200404-445OC, résumé)
(en) Hoeper MM, Halank M, Marx C, Hoeffken G, Winkler J et al., « Bosentan therapy for portopulmonary hypertension », Eur Respir J, vol. 25, n^o 3,‎ 2005, p. 502–8. (PMID 15738295, DOI 10.1183/09031936.05.00080804, résumé)

(en) Galiè N, Rubin L, Hoeper M et al., « Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial », Lancet, vol. 371, n^o 9630,‎ 2008, p. 2093–2100 (PMID 18572079, DOI 10.1016/S0140-6736(08)60919-8, lire en ligne)